drugset / Trial / NCT07367932

Comparative Study of Crisaborole vs. Tacrolimus in Atopic Dermatitis

NCT07367932

Phase 4 Not yet recruiting 30 enrolled Cairo University
RandomizedParallel-groupOpen-labelTreatment

Summary

This study will compare the efficacy and safety of crisaborole ointment with tacrolimus ointment, in the treatment of patients with mild-to-moderate atopic dermatitis.

Timeline

Start
2026-02
Primary completion
2026-04
Completion
2026-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Crisaborole Small molecule 2 % Topical
Comparator Tacrolimus Small molecule 0.03 % Topical

Indications